Another study reported in December 2025, suggested GLP-1 drugs may be involved in a rare subtype of a hereditary tumor called neuroendocrine neoplasm
This does not make NAD+ a hangover cure, an antidote, or a reason to drink more comfortably
In addition, the direct format removes the need for water or preparation, supporting consistent daily use
Retatrutide through a research peptide supplier comes in at a fraction of that, especially at maintenance doses
There could be a way around this uptake problem though
Education & Support: Through webinars, patient education materials, and community programs, Ascend Medical will empower patients with evidence based information about GLP-1 therapies and sustainable weight management